Total Payments
$2,800
2024 Payments
$998.52
Companies
33
Transactions
118
Medicare Patients
909
Medicare Billing
$34,500
Payment Breakdown by Category
Food & Beverage$2,676 (95.6%)
Other$123.95 (4.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,676 | 117 | 95.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $123.95 | 1 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $304.02 | 14 | $0 (2024) |
| UROGEN PHARMA, INC. | $272.98 | 13 | $0 (2024) |
| Teleflex LLC | $270.65 | 2 | $0 (2023) |
| Astellas Pharma US Inc | $212.38 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $183.17 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $169.43 | 8 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $167.21 | 4 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $140.04 | 2 | $0 (2024) |
| Corcept Therapeutics | $115.73 | 1 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $100.92 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $998.52 | 39 | ABBVIE INC. ($191.87) |
| 2023 | $981.17 | 43 | Teleflex LLC ($147.95) |
| 2022 | $690.75 | 34 | Teleflex LLC ($122.70) |
| 2021 | $129.71 | 2 | Corcept Therapeutics ($115.73) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $21.14 | General |
| Category: Prostate cancer | ||||||
| 11/12/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/04/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Urology | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/15/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/11/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/10/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/31/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Urology | ||||||
| 08/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: UROLOGY | ||||||
| 08/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/13/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $31.43 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $120.68 | General |
| Category: UROLOGY | ||||||
| 06/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: UROLOGY | ||||||
| 05/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 730 | 843 | $119,022 | $27,481 |
| 2022 | 7 | 179 | 221 | $24,324 | $7,019 |
Total Patients
909
Total Services
1,064
Medicare Billing
$34,500
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 140 | $34,671 | $10,150 | 29.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 45 | $14,292 | $3,667 | 25.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 64 | $9,516 | $3,225 | 33.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $9,390 | $1,853 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 34 | $7,361 | $1,810 | 24.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 35 | 52 | $5,824 | $1,656 | 28.4% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 12 | 16 | $6,880 | $1,388 | 20.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,255 | $702.30 | 21.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 159 | 187 | $4,634 | $632.34 | 13.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 63 | 74 | $6,953 | $495.20 | 7.1% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 53 | 59 | $3,045 | $466.69 | 15.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 18 | 18 | $1,278 | $306.34 | 24.0% |
| 51700 | Simple bladder irrigation and/or instillation | Facility | 2023 | 13 | 15 | $5,145 | $289.05 | 5.6% |
| 87088 | Bacterial urine culture | Office | 2023 | 32 | 34 | $1,326 | $269.62 | 20.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 26 | 26 | $832.00 | $210.49 | 25.3% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 20 | 22 | $2,310 | $186.55 | 8.1% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 20 | 22 | $2,310 | $174.24 | 7.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 49 | $11,172 | $3,748 | 33.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 41 | $5,945 | $1,861 | 31.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 13 | $2,561 | $767.04 | 30.0% |
| 87086 | Bacterial colony count, urine | Office | 2022 | 26 | 29 | $1,131 | $222.27 | 19.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 44 | 56 | $1,344 | $188.06 | 14.0% |
| 87088 | Bacterial urine culture | Office | 2022 | 15 | 16 | $624.00 | $119.74 | 19.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 15 | 17 | $1,547 | $113.77 | 7.4% |
About Margaret Sutter
Margaret Sutter is a Family healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2015. The National Provider Identifier (NPI) number assigned to this provider is 1124407986.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Margaret Sutter has received a total of $2,800 in payments from pharmaceutical and medical device companies, with $998.52 received in 2024. These payments were reported across 118 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,676).
As a Medicare-enrolled provider, Sutter has provided services to 909 Medicare beneficiaries, totaling 1,064 services with total Medicare billing of $34,500. Data is available for 2 years (2022–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Cincinnati, OH
- Active Since 05/27/2015
- Last Updated 06/16/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1124407986
Products in Payments
- UROLIFT (Device) $270.65
- BOTOX (Biological) $270.31
- GEMTESA (Drug) $216.06
- JELMYTO (Drug) $213.56
- Myrbetriq (Drug) $197.30
- ERLEADA (Drug) $169.43
- KEYTRUDA (Biological) $122.03
- AQUABEAM SYSTEM (Device) $120.68
- Korlym (Drug) $115.73
- Nubeqa (Drug) $100.92
- XIAFLEX (Biological) $78.84
- Axonics (Device) $78.62
- XYOSTED (Drug) $73.80
- LYNPARZA (Drug) $73.61
- YONSA (Drug) $62.07
- LYNPARZA (Biological) $61.14
- CAMCEVI (Drug) $38.71
- Trelstar (Drug) $37.40
- LUPRON DEPOT (Drug) $33.71
- PROVENGE (Drug) $31.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Cincinnati
Jillian Hunt, Fnp-C, FNP-C
Family — Payments: $114,728
Family $114,728
George Knight, Rn, Cnp, RN, CNP
Family — Payments: $99,023
Family $99,023
Mrs. Lindsey Spencer, Cnp, CNP
Family — Payments: $46,461
Family $46,461
Mrs. Annette Lavender, Msn, Aprn-Bc, MSN, APRN-BC
Family — Payments: $9,934
Family $9,934
Melissa Helton, Np-C, NP-C
Family — Payments: $8,477
Family $8,477
Julia Menetrey, Cnp, CNP
Family — Payments: $8,447
Family $8,447